Dador looks at how one peptide treatment is being used in dental care for oral health. The clip is short on names and details.
Recap by typeshit. Post by Facebook on Facebook.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
The Ministry of Health is asking the healthcare sector to promote careful use of weight and metabolic drugs, warning that misuse could carry risks.
OncoDaily covers a GCOS 2026 talk on where artificial intelligence and GLP-1 drugs could take heart care for cancer patients.
Loading…